RespireRx Pharmaceuticals Announces Preliminary Top-Line Analysis of Data from Duke University Phase 2A Clinical Trial of CX1739
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements